William S. Korinek
Amministratore Delegato presso Astrocyte Pharmaceuticals, Inc.
Profilo
William S.
Korinek is the founder and CEO of Astrocyte Pharmaceuticals, Inc. which was founded in 2014.
He is currently a partner at Dreavent, Inc. where he holds the title of Partner.
Dr. Korinek was a Vice President at Pfizer Inc. from 2009 to 2014.
He received his doctorate degree from Harvard University in 2000 and his undergraduate degree from Concordia College (Minnesota) in 1995.
Posizioni attive di William S. Korinek
Società | Posizione | Inizio |
---|---|---|
Astrocyte Pharmaceuticals, Inc.
Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Amministratore Delegato | 01/08/2014 |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | Investitore di Private Equity | - |
Precedenti posizioni note di William S. Korinek
Società | Posizione | Fine |
---|---|---|
PFIZER, INC. | Investitore di Private Equity | 01/07/2014 |
Formazione di William S. Korinek
Harvard University | Doctorate Degree |
Concordia College (Minnesota) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PFIZER, INC. | Health Technology |
Aziende private | 2 |
---|---|
Astrocyte Pharmaceuticals, Inc.
Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Borsa valori
- Insiders
- William S. Korinek